• 한국전기전자재료학회:학술대회논문집
• /
• 한국전기전자재료학회 2002년도 추계학술대회 논문집 Vol.15
• /
• pp.518-521
• /
• 2002

New luminescent material, 6,11-Dihydroxy-5,12-naphthacenedione$(Alq_2-Ncd)$ was synthesized. And extended efforts have been made to obtain high-performance electro-luminescent(EL) devices, since the first report of organic light-emitting diodes(OLEDs) based on tris-(8-hydroxy-quinoline)aluminum$(Alq_3)$ Current-voltage characteristics, brightness-voltage characteristics, luminous efficiency and quantum efficiency were measured at room temperature. The maximum wavelength of the EL is at around 504nm and the brightness is up to $2702[cd/m^2]$ with the maximum efficiency up to 3.91 [1m/W]. This study indicates not only the sterical effect but also some other effect would be responsible for the change of the emission wavelength.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권6호
• /
• pp.3909-3919
• /
• 2013

The aim of the present investigation was to evaluate the effect of A ferruginea extract on Dalton's lymphoma ascites (DLA) induced tumours in BALB/c mice. Experimental animals received A ferruginea extract (10 mg/kg.b.wt) intraperitoneally for 14 consecutive days after DLA tumor challenge. Treatment with extract significantly increased the life span, total white blood cell (WBC) count and haemoglobin (Hb) content and decreased the level of serum aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), gamma glutamyl transferase (${\gamma}$-GT) and nitric oxide (NO) in DLA bearing ascites tumor models. In addition, administration of extract significantly decreased the tumour volume and body weight in a DLA bearing solid tumor model. The levels of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-${\alpha}$), interleukin-1 beta (IL-$1{\beta}$), interleukin-6 (IL-6) and granulocyte monocyte-colony stimulating factor (GM-CSF), as well as pro-angiogenic growth factors such as vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) were elevated in solid tumour controls, but significantly reduced by A ferruginea administration. On the other hand, the extract stimulated the production of interleukin-2 (IL-2) and interferon-gamma (IFN-${\gamma}$) in animals with DLA induced solid tumours. Increase in $CD4^+$ T-cell population suggested strong immunostimulant activity for this extract. GC/MS and LC/MS analysis showed quinone, quinoline, imidazolidine, pyrrolidine, cyclopentenone, thiazole, pyrazole, catechin and coumarin derivatives as major compounds present in the A ferruginea methanolic extract. Thus, the outcome of the present study suggests that A ferruginea extract has immunomodulatory and tumor inhibitory activities and has the potential to be developed as a natural anticancer agent.

• 한국전기전자재료학회:학술대회논문집
• /
• 한국전기전자재료학회 2009년도 하계학술대회 논문집
• /
• pp.275-276
• /
• 2009

We have studied physical properties of organic light-emitting diodes (OLEDs) in a device with 7,7,8,8-tetracyanoquinodimethane (TCNQ). Since the TCNQ has a high electron affinity, it is widely used for a charge-transport and injection layer. And the TCNQ-derivatives have also been used to control the conductivity of the materials. It is known that a charge injection and transport in OLEDs with a TCNQ-derivative enhances a performance of the devices such as operating voltage and efficiency. To see how the TCNQ affects on the device performance, we have made a reference device in a structure of ITO(170nm)/TPD(40nm)/$Alq_3$(60nm)/LiF(0.5nm)/Al(100nm). And several type of devices were manufactured by doping TCNQ either in TPD or $Alq_3$ layer. The TCNQ layer was also formed in between the organic layers. N,N'-diphenyl-N,N'-di(m-tolyl)-benzidine (TPD), tri(8-hydroxy quinoline) aluminium ($Alq_3$), and TCNQ layers were formed by thermal evaporation at a pressure of $10^{-6}$ torr. The deposition rate was $1.0{\sim}1.5\;{\AA}/s$ for TPD, and $1.0{\sim}1.5\;{\AA}$ for $Alq_3$. The LiF was thermally evaporated at a deposition rate of $0.2\;{\AA}/s$ successively. The device with TCNQ-derivative improved the turn-on voltage compared to the one without TCNQ-derivative.

• 공업화학
• /
• 제7권6호
• /
• pp.1096-1104
• /
• 1996

새로운 항균제 및 항종양제를 합성하기 위하여 norfloxacin(8) 또는 ciprofloxacin(9)이 pteroic acid의 C-9위치에 치환되고 C-2 위치에 아미노기 대신 $CH_3$기가 치환된 새로운 pteroic acid 유도체 13a와 13b를 합성하였다. 이는 출발 물질인 norfloxacin과 ciprofloxacin의 piperazine N-4 위치에 2-amino-3-cyano-5-chloro-methylpyrazine(20)을 결합하여 1-alkyl(ethyl, cyclopropyl)-6-fluoro-1,4-dihydro-4-oxo-7-[[4-N- (2-amino-3-cyanopyrazin-5-yl)methyl]piperazin-1-yl]-3-quinolinecarboxytic acid(12a, 12b)를 합성하였다. 이를 각각 acetamidine. HCl과 고리화시켜 C-2 위치에 아미노기 대신 $CH_3$기가 치환된 새로운 pteroic acid 유도체 135와 13b를 각각 76.2%와 82.8%의 수율로 합성하였다. 그리고 이들 화합물에 대한 항균활성의 측정은 Pseudomonas aeruginosa ATCC9027을 포함하여 Gram-positive와 Gram-negative bacteria에 대하여 검토한 결과 합성한 화합물 13a와 13b는 일반적으로 norfloxacin보다 낮은 항균활성을 나타냈다.